Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • tranSMART, IDBS, JAX and more: News from August 2016

    Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from tranSMART, JAX, Internet2, IDBS, Synthego, and more.

    Aug 30, 2016
  • The Genetics of Type 2 Diabetes Is a Mess

    Pacific Standard | A recent study shows why genetic advances in medicine are so challenging.

    Aug 29, 2016
  • Digitizing The Pharma Research Value Chain For Faster Drug Discovery Through Precompetitive Collaboration

    Bio-IT World Contributed Commentary | The global pharmaceutical industry is at a crossroads. It is, therefore, imperative for pharma organizations to reimagine their research value chain, in order to accelerate product innovation, and boost molecule pipelines during the discovery stage.

    Aug 26, 2016
  • Stealthy Biotech Revives Stalled Parkinsons Drug Reveals Plans In Alzheimers and ALS

    Forbes | Denali Therapeutics, the stealthy South San Francisco biotech startup that raised $217 million last year to fight Alzheimer's, Parkinson's and ALS, is finally lifting the curtain on its plans this morning.

    Aug 25, 2016
  • Obama’s science legacy betting big on biomedical science

    Nature News & Comment | Ambitious bids to map the brain and cure cancer have not boosted overall research funding.

    Aug 22, 2016
  • With $14 Billion Purchase Pfizer Signals That Cancer Drug Prices Will Remain High

    Forbes | Pfizer says it will purchase biotechnology upstart Medivation for $14 billion in cash. The main prize in the deal: Medivation's prostate cancer drug, Xtandi, which costs $120,000 a year.

    Aug 22, 2016
  • Mass Innovation Labs Host Space for Growing Biotech

    Bio-IT World “Something that the industry doesn’t really talk about is the cost of doing research,” says Amrit Chaudhuri, CEO of Mass Innovation Labs in Cambridge, Mass. Running a lab can cost hundreds of dollars per square foot, Chaudhuri says, but Mass Innovation Labs offers an alternative.

    Aug 18, 2016
  • Lies damn lies and CRISPR the legal battle escalates

    STAT | The gloves are off in the legal fight over CRISPR genome editing patents, as the latest documents filed in the case make clear.

    Aug 18, 2016
  • ExAC Project Pins Down Rare Gene Variants

    Nature News & Comment | Catalogue of genetic information from some 60,000 people reveals unexpected surprises - and highlights the need to make genomic data publicly accessible to aid studies of rare diseases.

    Aug 17, 2016
  • ARM pact Will Help Intel Woo Apple Into New Chip Deal

    Computerworld | The chances of Apple's using Intel's factories to have its iPhone and iPad chips made have just rocketed up.

    Aug 17, 2016
  • «
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196 (current)
  • 197
  • 198
  • 199
  • 200
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy